Clinical Trials Market in US 2026-2030

Description

The clinical trials market in us is forecasted to grow by USD 7021.4 mn during 2025-2030, accelerating at a CAGR of 5.4% during the forecast period. The report on the clinical trials market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by robust growth in research and development expenditures, proliferation of outsourcing to contract research organizations, technological advancements and adoption of digital and decentralized trial models.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2026
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	5.2%
CAGR	5.4%
Incremental Value	$7021.4 mn

Technavio's clinical trials market in us is segmented as below:

By Type

Phase III
Phase I
Phase II
Phase IV

By Service Type

Interventional studies
Observational studies
Expanded access studies

By Indication

Oncology
CNS
Autoimmune or inflammation
Others

Geography

North America
- US

This study identifies the ascendancy of decentralized and hybrid trial models as one of the prime reasons driving the clinical trials market in us growth during the next few years. Also, convergence of artificial intelligence and real world evidence and proliferation of complex and adaptive trial designs in era of precision medicine will lead to sizable demand in the market.

The report on the clinical trials market in us covers the following areas:

Clinical trials market in us sizing
Clinical trials market in us forecast
Clinical trials market in us industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical trials market in us vendors that include Caidya, Celerion, CenExel Clinical Research, Charles River Laboratories International Inc., Clario, EPS International Holdings Co, Fortrea Holdings Inc, ICON plc, IQVIA Holdings Inc., Laboratory Holdings Inc., Medelis Inc., Medpace Holdings Inc., Parexel International Corp., PROMETRIKA LLC, Rho Inc., Suvoda LLC, Syneos Health Inc., Thermo Fisher Scientific Inc., Veristat LLC. Also, the clinical trials market in us analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR76518

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Country Market Characteristics
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Service Type
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030

3 Market Landscape

3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis

4 Market Sizing

4.1 Market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

5.1 Clinical Trials Market in US 2020 - 2024
- Historic Market Size - Data Table on Clinical Trials Market in US 2020 - 2024 ($ million)
5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
5.3 Service Type segment analysis 2020 - 2024
- Historic Market Size - Service Type Segment 2020 - 2024 ($ million)
5.4 Indication segment analysis 2020 - 2024
- Historic Market Size - Indication Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on clinical trials market in US
6.2 Impact of geopolitical conflicts on clinical trials market in US

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition

8 Market Segmentation by Type

8.1 Market segments
8.2 Comparison by Type
8.3 Phase III - Market size and forecast 2025-2030
8.4 Phase I - Market size and forecast 2025-2030
8.5 Phase II - Market size and forecast 2025-2030
8.6 Phase IV - Market size and forecast 2025-2030
8.7 Market opportunity by Type
- Market opportunity by Type ($ million)

9 Market Segmentation by Service Type

9.1 Market segments
9.2 Comparison by Service Type
9.3 Interventional studies - Market size and forecast 2025-2030
9.4 Observational studies - Market size and forecast 2025-2030
9.5 Expanded access studies - Market size and forecast 2025-2030
9.6 Market opportunity by Service Type
- Market opportunity by Service Type ($ million)

10 Market Segmentation by Indication

10.1 Market segments
10.2 Comparison by Indication
10.3 Oncology - Market size and forecast 2025-2030
10.4 CNS - Market size and forecast 2025-2030
10.5 Autoimmune or inflammation - Market size and forecast 2025-2030
10.6 Others - Market size and forecast 2025-2030
10.7 Market opportunity by Indication
- Market opportunity by Indication ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Drivers, Challenges, and Opportunity

12.1 Market drivers
- Robust growth in research and development expenditures
- Proliferation of outsourcing to contract research organizations
- Technological advancements and adoption of digital and decentralized trial models
12.2 Market challenges
- Systemic hurdles in patient recruitment and retention
- Escalating operational costs and logistical complexity
- Navigating dynamic and fragmented regulatory and data privacy landscape
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
12.4 Market opportunities
- Ascendancy of decentralized and hybrid trial models
- Convergence of artificial intelligence and real world evidence
- Proliferation of complex and adaptive trial designs in era of precision medicine

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 Caidya
- Caidya - Overview
- Caidya - Product / Service
- Caidya - Key offerings
- SWOT
14.5 Charles River Laboratories International Inc.
- Charles River Laboratories International Inc. - Overview
- Charles River Laboratories International Inc. - Business segments
- Charles River Laboratories International Inc. - Key offerings
- Charles River Laboratories International Inc. - Segment focus
- SWOT
14.6 Clario
- Clario - Overview
- Clario - Product / Service
- Clario - Key offerings
- SWOT
14.7 Fortrea Holdings Inc
- Fortrea Holdings Inc - Overview
- Fortrea Holdings Inc - Product / Service
- Fortrea Holdings Inc - Key offerings
- SWOT
14.8 ICON plc
- ICON plc - Overview
- ICON plc - Product / Service
- ICON plc - Key offerings
- SWOT
14.9 IQVIA Holdings Inc.
- IQVIA Holdings Inc. - Overview
- IQVIA Holdings Inc. - Business segments
- IQVIA Holdings Inc. - Key offerings
- IQVIA Holdings Inc. - Segment focus
- SWOT
14.10 Laboratory Holdings Inc.
- Laboratory Holdings Inc. - Overview
- Laboratory Holdings Inc. - Business segments
- Laboratory Holdings Inc. - Key news
- Laboratory Holdings Inc. - Key offerings
- Laboratory Holdings Inc. - Segment focus
- SWOT
14.11 Medelis Inc.
- Medelis Inc. - Overview
- Medelis Inc. - Product / Service
- Medelis Inc. - Key offerings
- SWOT
14.12 Medpace Holdings Inc.
- Medpace Holdings Inc. - Overview
- Medpace Holdings Inc. - Product / Service
- Medpace Holdings Inc. - Key offerings
- SWOT
14.13 Parexel International Corp.
- Parexel International Corp. - Overview
- Parexel International Corp. - Product / Service
- Parexel International Corp. - Key offerings
- SWOT
14.14 Rho Inc.
- Rho Inc. - Overview
- Rho Inc. - Product / Service
- Rho Inc. - Key offerings
- SWOT
14.15 Suvoda LLC
- Suvoda LLC - Overview
- Suvoda LLC - Product / Service
- Suvoda LLC - Key offerings
- SWOT
14.16 Syneos Health Inc.
- Syneos Health Inc. - Overview
- Syneos Health Inc. - Product / Service
- Syneos Health Inc. - Key offerings
- SWOT
14.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
14.18 Veristat LLC
- Veristat LLC - Overview
- Veristat LLC - Product / Service
- Veristat LLC - Key offerings
- SWOT

15 Appendix

15.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations